azomycin has been researched along with Asymptomatic Conditions in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Castellanos Domínguez, YZ; Cucunubá, ZM; Hernández, Y; Herrera, VM; Pérez Carreño, JG; Prado, NG; Váquiro Herrera, E; Vásquez, SM; Villar, JC | 1 |
| Muzny, CA; Schwebke, JR | 1 |
1 review(s) available for azomycin and Asymptomatic Conditions
| Article | Year |
|---|---|
The clinical spectrum of Trichomonas vaginalis infection and challenges to management.
Topics: Antiprotozoal Agents; Asymptomatic Diseases; Female; Humans; Male; Molecular Diagnostic Techniques; Nitroimidazoles; Sexually Transmitted Diseases; Trichomonas Infections; Trichomonas vaginalis; Urethritis; Vaginitis | 2013 |
1 trial(s) available for azomycin and Asymptomatic Conditions
| Article | Year |
|---|---|
Nifurtimox versus benznidazole or placebo for asymptomatic Trypanosoma cruzi infection (Equivalence of Usual Interventions for Trypanosomiasis - EQUITY): study protocol for a randomised controlled trial.
Topics: Adult; Aged; Asymptomatic Diseases; Chagas Disease; Colombia; Female; Humans; Male; Middle Aged; Multicenter Studies as Topic; Nifurtimox; Nitroimidazoles; Randomized Controlled Trials as Topic; Therapeutic Equivalency; Time Factors; Treatment Outcome; Trypanocidal Agents; Trypanosoma cruzi; Young Adult | 2019 |